Study compares laparoscopic sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) in obese patients, finding both procedures have low, comparable perioperative risks and complications, challenging the criteria for selecting between the two surgeries.
MSD sets sights on bispecific antibody market with Curon acqusition – Pharmaceutical Technology
CN201 is a T cell engager bispecific antibody in development for the treatment of B cell non-Hodgkin lymphoma (B-NHL) and B cell acute lymphoblastic leukemia